Hos seks patienter, som fortsatte med hyperlipidæmi på monoterapi, blev der givet kombinationsterapi med simvastatin (40 mg/ dag) og gemfibrozil (450 mg/ dag).
In six patients who remained with a hyperlipidaemia on monotherapy combination drug therapy with simvastatin (40 mg/ day) and gemfibrozil (450 mg/ day) was given.